A mathematical model for ketosis-prone diabetes suggests the existence of multiple pancreatic β-cell inactivation mechanisms
Preprint
Abstract
Ketosis-prone diabetes mellitus (KPD) is a subtype of type 2 diabetes, which presents much like type 1 diabetes, with dramatic hyperglycemia and ketoacidosis. Although KPD patients are initially insulin-dependent, after a few months of insulin treatment, roughly 70% undergo near-normoglycemia remission and can maintain blood glucose without insulin, as in early type 2 diabetes or prediabetes. Here, we propose that these phenomena can be explained by the existence of a fast, reversible glucotoxicity process, which may exist in all people but be more pronounced in those susceptible to KPD. We develop a simple mathematical model of the pathogenesis of KPD, which incorporates this assumption, and show that it reproduces the phenomenology of KPD, including variations in the ability for patients to achieve and sustain remission. These results suggest that a variation of our model may be able to quantitatively describe variations in the course of remission among individuals with KPD.Keywords
All Related Versions
- Version 1, 2024-09-17, eLife preprints (Unconfirmed version)
- Published version: eLife, 13.
This publication has 60 references indexed in Scilit:
- Population insulin sensitivity from sparsely sampled oral glucose tolerance testsMetabolism, 2020
- Pancreatic β Cell Dedifferentiation in Diabetes and Redifferentiation following Insulin TherapyCell Metabolism, 2014
- Hepatic insulin clearance is the primary determinant of insulin sensitivity in the normal dogObesity, 2013
- The long lifespan and low turnover of human islet beta cells estimated by mathematical modelling of lipofuscin accumulationDiabetologia, 2009
- Effect of intensive insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trialThe Lancet, 2008
- A Model of β -Cell Mass, Insulin, and Glucose Kinetics: Pathways to DiabetesJournal of Theoretical Biology, 2000
- Glycemic Control With Diet, Sulfonylurea, Metformin, or Insulin in Patients With Type 2 Diabetes MellitusProgressive Requirement for Multiple Therapies (UKPDS 49)JAMA, 1999
- Tissue-Specific Knockout of the Insulin Receptor in Pancreatic β Cells Creates an Insulin Secretory Defect Similar to that in Type 2 DiabetesCell, 1999
- Beta-cell hypersensitivity for glucose precedes loss of glucose-induced insulin secretion in 90% pancreatectomized ratsDiabetologia, 1993
- Solving Ordinary Differential Equations II1991